PubPeer
The online Journal club
login
create account
Home
Publications
The druggable genome: Evaluation of drug targets in clinical trials suggests major shifts in molecular class and indication
The Annual Review of Pharmacology and Toxicology (2014) -
Comments
pubmed: 24016212 doi: 10.1146/annurev-pharmtox-011613-135943 issn: 0362-1642 issn: 1545-4304
Mathias Rask-Andersen, Surendar Masuram, Helgi B. Schiöth
Go to article
Go to preprint
Annual Reviews
Comments awaiting moderation ({{totalComments}})
Review last reports ({{totalReports}})
Review last email suggestions ({{totalPendingEmails}})
Last month's whitelisted comments ({{totalWhitelistedComments}})